MedPath

University Of Maryland, Baltimore

đŸ‡ē🇸United States
Ownership
-
Established
1807-01-01
Employees
7.3K
Market Cap
-
Website
http://www.umaryland.edu

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)

Phase 2
Completed
Conditions
Cancer of Head and Neck
Interventions
Drug: Erbitux, Paclitaxel & Carboplatin
Radiation: Radiation
First Posted Date
2006-06-22
Last Posted Date
2019-08-19
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
43
Registration Number
NCT00343083
Locations
đŸ‡ē🇸

University of Maryland & Baltimore VA medical centre, Baltimore, Maryland, United States

Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2006-06-14
Last Posted Date
2021-05-11
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
6
Registration Number
NCT00336778
Locations
đŸ‡ē🇸

University of Maryland Baltimore, Institute of Human Virology, Baltimore, Maryland, United States

đŸ‡ē🇸

University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

Terminated
Conditions
Barrett Esophagus
Deglutition Disorders
Neoplasm
Esophageal Neoplasms
GERD
First Posted Date
2006-05-04
Last Posted Date
2022-02-08
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
23
Registration Number
NCT00321958
Locations
đŸ‡ē🇸

University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, Maryland, United States

Assessment of Coronary Artery Disease by Hybrid PET/CT

Not Applicable
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: Hybrid PET/CT
First Posted Date
2006-05-03
Last Posted Date
2021-06-09
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
30
Registration Number
NCT00320931
Locations
đŸ‡ē🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

Cognitive Remediation for Schizophrenia

Not Applicable
Completed
Conditions
Schizophrenia
First Posted Date
2006-02-22
Last Posted Date
2021-07-21
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
50
Registration Number
NCT00295048
Locations
đŸ‡ē🇸

MOSAIC Community Services, Catonsville, Maryland, United States

đŸ‡ē🇸

University of Maryland - Walter P. Carter Center, Baltimore, Maryland, United States

đŸ‡ē🇸

VA Maryland Health Care Systen, Baltimore, Maryland, United States

Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients

Not Applicable
Completed
Conditions
Substance Dependence
Mood Disorders
Schizophrenia
Interventions
Behavioral: Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
Behavioral: Supportive Treatment in Addiction Recovery (STAR)
Behavioral: Critical Time Intervention (CTI)
First Posted Date
2006-02-22
Last Posted Date
2022-02-18
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
293
Registration Number
NCT00295139
Locations
đŸ‡ē🇸

University of Maryland, Baltimore, Baltimore, Maryland, United States

đŸ‡ē🇸

VA Maryland Health Care System, Baltimore, Maryland, United States

đŸ‡ē🇸

Health Care for the Homeless, Baltimore, Maryland, United States

and more 1 locations

Alcohol Use Disorders in Schizophrenia

Not Applicable
Completed
Conditions
Alcohol Dependence
Schizophrenia
Mood Disorders
Alcohol Abuse
Interventions
Behavioral: Supportive Treatment in Addiction Recovery (STAR)
First Posted Date
2006-01-23
Last Posted Date
2020-04-06
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
54
Registration Number
NCT00280813
Locations
đŸ‡ē🇸

University of Maryland, Baltimore, Baltimore, Maryland, United States

đŸ‡ē🇸

Healthcare for the Homeless, Baltimore, Maryland, United States

đŸ‡ē🇸

VA Maryland Healthcare System, Baltimore, Maryland, United States

and more 1 locations

Renal Effects of Intrarenal Nesiritide

Phase 4
Terminated
Conditions
Heart Failure, Congestive
Interventions
First Posted Date
2005-12-28
Last Posted Date
2019-12-23
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
2
Registration Number
NCT00270829
Locations
đŸ‡ē🇸

University of Maryland, Baltimore, Maryland, United States

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Not Applicable
Completed
Conditions
Fasciitis, Necrotizing
Severe Necrotizing Skin and Soft Tissue Infections
Fournier's Gangrene
Interventions
First Posted Date
2005-12-05
Last Posted Date
2022-01-27
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
25
Registration Number
NCT00261807
Locations
đŸ‡ē🇸

R Adams Cowley Shock Trauma Center, U. of Maryland Medical Center, Baltimore, Maryland, United States

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Phase 1
Completed
Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
Biological: MAGE-A3
Biological: HPV-16 vaccine
First Posted Date
2005-11-23
Last Posted Date
2019-10-17
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
17
Registration Number
NCT00257738
Locations
đŸ‡ē🇸

University of Maryland School of Medicine, Baltimore, Maryland, United States

Š Copyright 2025. All Rights Reserved by MedPath